Abeona Therapeutics Statistics
 Total Valuation
 ABEO has a market cap or net worth of $245.11 million. The enterprise value is $43.67 million.
   Important Dates
 The next estimated earnings date is Thursday, November 13, 2025, before market open.
 | Earnings Date  | Nov 13, 2025 | 
| Ex-Dividend Date  | n/a | 
  Share Statistics
 ABEO has 51.28 million shares outstanding. The number of shares has increased by 92.58% in one year.
 | Current Share Class  | 51.28M | 
| Shares Outstanding  | 51.28M | 
| Shares Change (YoY)  | +92.58% | 
| Shares Change (QoQ)  | +33.87% | 
| Owned by Insiders (%)  | 10.96% | 
| Owned by Institutions (%)  | 48.62% | 
| Float  | 35.34M | 
   Valuation Ratios
 The trailing PE ratio is 4.83.
 | PE Ratio  | 4.83 | 
| Forward PE  | n/a | 
| PS Ratio  | 612.78 | 
| Forward PS  | 3.15 | 
| PB Ratio  | 1.50 | 
| P/TBV Ratio  | 1.50 | 
| P/FCF Ratio  | n/a | 
| P/OCF Ratio  | n/a | 
| PEG Ratio  | n/a | 
 Financial Ratio History  Enterprise Valuation
  | EV / Earnings  | 0.76 | 
| EV / Sales  | 109.17 | 
| EV / EBITDA  | n/a | 
| EV / EBIT  | n/a | 
| EV / FCF  | n/a | 
  Financial Position
 The company has a current ratio of 6.73, with a Debt / Equity ratio of 0.15.
 | Current Ratio  | 6.73 | 
| Quick Ratio  | 6.58 | 
| Debt / Equity  | 0.15 | 
| Debt / EBITDA  | n/a | 
| Debt / FCF  | n/a | 
| Interest Coverage  | -18.01 | 
   Financial Efficiency
 Return on equity (ROE) is 48.34% and return on invested capital (ROIC) is -32.80%.
 | Return on Equity (ROE)  | 48.34% | 
| Return on Assets (ROA)  | -24.50% | 
| Return on Invested Capital (ROIC)  | -32.80% | 
| Return on Capital Employed (ROCE)  | -35.21% | 
| Revenue Per Employee  | $2,941 | 
| Profits Per Employee  | $420,897 | 
| Employee Count | 136 | 
| Asset Turnover  | 0.00 | 
| Inventory Turnover  | n/a | 
  Taxes
 In the past 12 months, ABEO has paid $15.51 million in taxes.
 | Income Tax  | 15.51M | 
| Effective Tax Rate  | 21.32% | 
  Stock Price Statistics
 The stock price has decreased by -23.52% in the last 52 weeks. The beta is 1.42, so ABEO's price volatility has been higher than the market average.
 | Beta (5Y)  | 1.42 | 
| 52-Week Price Change  | -23.52% | 
| 50-Day Moving Average  | 5.79 | 
| 200-Day Moving Average  | 5.78 | 
| Relative Strength Index (RSI)  | 31.06 | 
| Average Volume (20 Days)  | 1,422,121 | 
  Short Selling Information
 The latest short interest is 9.19 million, so 17.92% of the outstanding shares have been sold short.
 | Short Interest  | 9.19M | 
| Short Previous Month  | 8.63M | 
| Short % of Shares Out  | 17.92% | 
| Short % of Float  | 26.00% | 
| Short Ratio (days to cover)  | 8.30 | 
  Income Statement
 In the last 12 months, ABEO had revenue of $400,000 and earned $57.24 million in profits. Earnings per share was $0.99.
 | Revenue | 400,000 | 
| Gross Profit  | -33.52M | 
| Operating Income  | -74.54M | 
| Pretax Income  | 72.75M | 
| Net Income  | 57.24M | 
| EBITDA  | -72.43M | 
| EBIT  | -74.54M | 
| Earnings Per Share (EPS)  | $0.99 | 
 Full Income Statement  Balance Sheet
 The company has $225.52 million in cash and $24.08 million in debt, giving a net cash position of $201.44 million or $3.93 per share.
 | Cash & Cash Equivalents  | 225.52M | 
| Total Debt  | 24.08M | 
| Net Cash  | 201.44M | 
| Net Cash Per Share  | $3.93 | 
| Equity (Book Value)  | 163.58M | 
| Book Value Per Share  | 3.19 | 
| Working Capital  | 197.75M | 
 Full Balance Sheet  Cash Flow
 In the last 12 months, operating cash flow was -$65.98 million and capital expenditures -$5.31 million, giving a free cash flow of -$71.29 million.
 | Operating Cash Flow  | -65.98M | 
| Capital Expenditures  | -5.31M | 
| Free Cash Flow  | -71.29M | 
| FCF Per Share  | -$1.39 | 
 Full Cash Flow Statement  Margins
  | Gross Margin  | n/a | 
| Operating Margin  | -18,634.00% | 
| Pretax Margin  | 18,188.50% | 
| Profit Margin  | 14,310.50% | 
| EBITDA Margin  | n/a | 
| EBIT Margin  | n/a | 
| FCF Margin  | n/a | 
  Dividends & Yields
 ABEO does not appear to pay any dividends at this time.
 | Dividend Per Share  | n/a | 
| Dividend Yield  | n/a | 
| Dividend Growth (YoY)  | n/a | 
| Years of Dividend Growth  | n/a | 
| Payout Ratio  | n/a | 
| Buyback Yield  | -92.58% | 
| Shareholder Yield  | -92.58% | 
| Earnings Yield  | 23.35% | 
| FCF Yield  | -29.09% | 
 Dividend Details   Analyst Forecast
 The average price target for ABEO is $18.20, which is 280.75% higher than the current price. The consensus rating is "Strong Buy".
 | Price Target  | $18.20 | 
| Price Target Difference  | 280.75% | 
| Analyst Consensus  | Strong Buy | 
| Analyst Count  | 5 | 
| Revenue Growth Forecast (5Y)  | n/a | 
| EPS Growth Forecast (5Y)  | n/a | 
 Stock Forecasts  Fair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value  | n/a | 
| Lynch Upside  | n/a | 
| Graham Number  |  | 
| Graham Upside  |  | 
  Stock Splits
 The last stock split was on July 5, 2022. It was a reverse split with a ratio of 1:25.
 | Last Split Date  | Jul 5, 2022 | 
| Split Type  | Reverse | 
| Split Ratio  | 1:25 | 
  Scores
 ABEO has an Altman Z-Score of -2.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
 | Altman Z-Score  | -2.26 | 
| Piotroski F-Score  | 2 |